Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
VKTX
#1287
Viking Therapeutics, Inc
33.8
4
+6.28%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
+6.28%
Monthly Change
+7.46%
6 month change
+25.94%
Year Change
+20.43%
Previous Close
31.8
4
Open
33.8
4
Bid
Ask
Low
33.8
4
High
33.8
4
Volume
112
Markets
US Stock Market
Healthcare
VKTX
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Dividends per share
—
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
—
News
Lilly's GLP-1 Blockbusters Drive 2025 Revenue Surge: What's Ahead?
Lilly vs. Novo Nordisk: Obesity Drug Giants' Face-Off in 2026
American Express, Oracle among market cap stock movers on Monday
Novo Nordisk Dives As Next-Gen Obesity Drug Lags Eli Lilly's Kingpin
Structure Therapeutics: The Dark Horse Has Taken The Lead - But Is It Enough? (GPCR)
Can LLY's Next-Gen Obesity Pipeline Sustain Growth Amid Competition?
Hims & Hers Faces New Hurdle In Weight-Loss Brawl With Novo Nordisk
NVO Crashes 21% in a Month: Is This an Indication to Sell the Stock?
Viking Therapeutics: Full-Speed Ahead (NASDAQ:VKTX)
Viking: Buyers Quietly Accumulating On Obesity Drugs Launch Potential (NASDAQ:VKTX)
Cisco and Micron among market cap stock movers on Thursday
How to Play Eli Lilly Stock Following a Robust Q4 Earnings Report